Literature DB >> 29349760

Advancements and Personalization of Breast Cancer Treatment Strategies in Radiation Therapy.

Meena S Moran1.   

Abstract

Significant technologic advances in radiation treatment delivery now allow for more personalized delivery considerations which incorporate individual patient characteristics (such as tumor location and patient anatomy) and more precise delivery in the breast conservation or post-mastectomy setting. The combined advancements with other treatment modalities (i.e., systemic therapy, surgical management) have had direct effects on local-regional management and outcomes such that currently, local-regional relapses after definitive treatment for localized disease are now rarely experienced. Recent advances in the radiation therapy field have come from careful patient selection for a variety of three-dimensional treatment delivery techniques and alternatives to conventional tangential radiation. These advances have been demonstrated to diminished acute/long-term toxicity, minimized dose to surrounding normal tissue structures such as the heart and lung, and ultimately result in an improvement in the therapeutic ratio for radiation treatment. This chapter discusses recent radiation innovations and appropriate patient selection for their application, for a more personalized approach to radiation therapy for breast cancer patients.

Entities:  

Keywords:  Breast cancer; Breast conservation therapy; Deep inspiration breath hold; Radiation therapy; Regional nodal radiation; Techniques

Mesh:

Year:  2018        PMID: 29349760     DOI: 10.1007/978-3-319-70197-4_7

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


  3 in total

1.  Is Proton Therapy a "Pro" for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.

Authors:  Mudit Chowdhary; Anna Lee; Sarah Gao; Dian Wang; Parul N Barry; Roberto Diaz; Neeti R Bagadiya; Henry S Park; James B Yu; Lynn D Wilson; Meena S Moran; Susan A Higgins; Christin A Knowlton; Kirtesh R Patel
Journal:  Front Oncol       Date:  2019-01-14       Impact factor: 6.244

2.  Upregulation of SHIP2 participates in the development of breast cancer via promoting Wnt/β-catenin signaling.

Authors:  Juan Zhou; Manman Di; Hui Han
Journal:  Onco Targets Ther       Date:  2019-08-30       Impact factor: 4.147

3.  Identification of potential biomarkers and metabolic pathways based on integration of metabolomic and transcriptomic data in the development of breast cancer.

Authors:  Yifei Yang; Yunhua Zhu; Xiaoyan Li; Xiuxia Zhang; Bin Yu
Journal:  Arch Gynecol Obstet       Date:  2021-03-31       Impact factor: 2.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.